• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and Validation of Discriminatory Dissolution Testing Method for Fast Dispersible Tablets of BCS Class II Drug.BCS II类药物速溶片的鉴别溶出度测试方法的开发与验证
Turk J Pharm Sci. 2020 Feb;17(1):74-80. doi: 10.4274/tjps.galenos.2018.90582. Epub 2020 Feb 19.
2
Development and Validation of a Discriminative Dissolution Medium for a Poorly Soluble Nutraceutical Tetrahydrocurcumin.一种难溶性营养保健品四氢姜黄素的鉴别性溶出介质的开发与验证
Turk J Pharm Sci. 2021 Oct 28;18(5):565-573. doi: 10.4274/tjps.galenos.2021.91145.
3
Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets.二甲双胍速释薄膜包衣片鉴别溶出方法的开发与验证
J Anal Methods Chem. 2019 Dec 10;2019:4296321. doi: 10.1155/2019/4296321. eCollection 2019.
4
Development and validation of new discriminative dissolution method for carvedilol tablets.卡维地洛片新的鉴别溶出方法的开发与验证
Indian J Pharm Sci. 2011 Sep;73(5):527-36. doi: 10.4103/0250-474X.99000.
5
Development of a Discriminative and Biorelevant Dissolution Test Method for Atorvastatin/Fenofibrate Combination with Appliance of Derivative Spectrophotometry.采用导数分光光度法建立阿托伐他汀/非诺贝特组合制剂的鉴别性和生物相关性溶出度测试方法。
Turk J Pharm Sci. 2019 Mar;16(1):62-68. doi: 10.4274/tjps.77698. Epub 2018 Dec 31.
6
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.开发一种在速释固定剂量青蒿琥酯/本芴醇片中溶出度测定法。
Malar J. 2020 Apr 7;19(1):139. doi: 10.1186/s12936-020-03209-5.
7
In Vitro Dissolution Profile of Dapagliflozin: Development, Method Validation, and Analysis of Commercial Tablets.达格列净的体外溶出曲线:开发、方法验证及市售片剂分析
Int J Anal Chem. 2017;2017:2951529. doi: 10.1155/2017/2951529. Epub 2017 Jul 31.
8
Development and Validation of a Discriminatory Dissolution Method for Rifaximin Products.建立并验证利福昔明制剂的鉴别溶出度方法。
J Pharm Sci. 2019 Jun;108(6):2112-2118. doi: 10.1016/j.xphs.2019.01.020. Epub 2019 Jan 24.
9
A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting.一种优化和制备用于恶心和呕吐的快速崩解片的新方法。
AAPS PharmSciTech. 2008;9(3):774-81. doi: 10.1208/s12249-008-9113-1. Epub 2008 Jun 27.
10
Development and Validation of a Discriminatory Dissolution Model for an Immediately Release Dosage Form by DOE and Statistical Approaches.通过 DOE 和统计方法开发和验证立即释放剂型的鉴别溶出模型。
AAPS PharmSciTech. 2021 Apr 21;22(4):140. doi: 10.1208/s12249-021-02011-z.

引用本文的文献

1
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.纳米技术在提高难溶性药物溶解度和生物利用度方面的进展。
Drug Des Devel Ther. 2024 May 1;18:1469-1495. doi: 10.2147/DDDT.S447496. eCollection 2024.
2
Effects of Apex Size on Dissolution Profiles in the USP II Paddle Apparatus.顶空大小对 USP II 桨法装置中溶出曲线的影响。
AAPS PharmSciTech. 2023 Dec 29;25(1):9. doi: 10.1208/s12249-023-02722-5.
3
Evaluating Novel Agarose-Based Buccal Gels Scaffold: Mucoadhesive and Pharmacokinetic Profiling in Healthy Volunteers.评估新型琼脂糖基口腔凝胶支架:健康志愿者的粘膜粘附性和药代动力学分析
Pharmaceutics. 2022 Jul 30;14(8):1592. doi: 10.3390/pharmaceutics14081592.
4
Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.用于模拟速释固体口服制剂进食条件的体外溶出度测试方法的开发。
AAPS J. 2022 Mar 11;24(2):40. doi: 10.1208/s12248-022-00690-5.

本文引用的文献

1
In vitro evaluation of domperidone mouth dissolving tablets.多潘立酮口腔崩解片的体外评价
Indian J Pharm Sci. 2010 Nov;72(6):822-5. doi: 10.4103/0250-474X.84607.
2
Comparison of various international guidelines for analytical method validation.各种分析方法验证国际指南的比较。
Pharmazie. 2007 Jan;62(1):4-14.
3
Optimization of dissolution test precision for a ketoprofen oral extended-release product.酮洛芬口服缓释制剂溶出度试验精度的优化
J Pharm Biomed Anal. 2003 Apr 24;32(1):159-65. doi: 10.1016/s0731-7085(03)00032-3.
4
Fast dispersible ibuprofen tablets.速溶布洛芬片
Eur J Pharm Sci. 2002 Apr;15(3):295-305. doi: 10.1016/s0928-0987(02)00011-8.

BCS II类药物速溶片的鉴别溶出度测试方法的开发与验证

Development and Validation of Discriminatory Dissolution Testing Method for Fast Dispersible Tablets of BCS Class II Drug.

作者信息

Bhatt Shailendra, Roy Dabashis, Kumar Manish, Saharan Renu, Malik Anuj, Saini Vipin

机构信息

Maharishi Markandeshwar (Deemed to be University), Maharishi Markandeshwar College of Pharmacy, Department of Pharmaceutics, Haryana, India.

Maharishi Markandeshwar University, Solan, India.

出版信息

Turk J Pharm Sci. 2020 Feb;17(1):74-80. doi: 10.4274/tjps.galenos.2018.90582. Epub 2020 Feb 19.

DOI:10.4274/tjps.galenos.2018.90582
PMID:32454764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7227868/
Abstract

OBJECTIVES

Fast dispersible tablets (FDTs) get dispersed very fast due to which the discrimination of drug release and their evaluation is difficult. Hence in the present study a new discriminatory dissolution method was developed and validated for FDTs of domperidone of BCS class II.

MATERIALS AND METHODS

FDTs of domperidone were prepared by direct compression method. The dissolution studies were performed in an eight-station Electrolab TDT-082 dissolution testing apparatus, analyzed by ultraviolet spectrophotometer and evaluated in different dissolution mediums i.e. sodium lauryl sulphate (0.5%, 1.0% and 1.5%) with fresh distilled water, simulated intestinal fluid pH 6.8, simulated gastric fluid pH 1.2 without enzymes, phosphate buffer solution (pH 6.8) and 0.1 N hydrochloric acid at different agitation speeds.

RESULTS

The developed method was validated in terms of specificity, accuracy, precision, linearity and robustness. Amongst the different mediums, 0.5% sodium lauryl sulfate (SLS) with distilled water was found to be optimum with higher rate of discriminatory power. The percentage recovery was found to be 96 to 100.12 % and the % relative standard deviation value for precision (intraday and interday) was found to be less than 1%. Also a dissolution profile of prepared FDTs were compared in distilled water containing 0.5% SLS using similarity (f2) and dissimilarity (f1) factor calculation which showed dissimilarity in release profile and confirms the discriminatory nature of developed method.

CONCLUSION

The discriminatory dissolution method for FDTs was developed and validated. All the obtained results were satisfactory, accurate and in range. The current method could be beneficial for formulation development and for assessment of quality of FDTs.

摘要

目的

速崩片(FDTs)分散速度极快,这使得药物释放的区分及其评估变得困难。因此,在本研究中,针对BCS II类多潘立酮的速崩片开发并验证了一种新的区分性溶出方法。

材料与方法

采用直接压片法制备多潘立酮速崩片。溶出度研究在八站式Electrolab TDT - 082溶出度测试装置中进行,用紫外分光光度计分析,并在不同溶出介质中进行评估,即含0.5%、1.0%和1.5%十二烷基硫酸钠的新鲜蒸馏水、pH 6.8的模拟肠液、无酶的pH 1.2模拟胃液、磷酸盐缓冲溶液(pH 6.8)以及0.1 N盐酸,在不同搅拌速度下进行。

结果

所开发的方法在特异性、准确性、精密度、线性和稳健性方面得到了验证。在不同介质中,含0.5%十二烷基硫酸钠(SLS)的蒸馏水被发现是具有较高区分能力的最佳介质。回收率为96%至100.12%,精密度(日内和日间)的相对标准偏差值小于1%。还使用相似性(f2)和不相似性(f1)因子计算比较了在含0.5% SLS的蒸馏水中制备的速崩片的溶出曲线,结果显示释放曲线不同,证实了所开发方法的区分性质。

结论

开发并验证了速崩片的区分性溶出方法。所有获得的结果均令人满意、准确且在范围内。当前方法可能有助于速崩片的制剂开发和质量评估。